Pharmacological Research (Jul 2025)

Knockout of SIN3B modulates transcriptional programs and cell survival in cutaneous melanoma

  • Larissa Satiko Alcantara Sekimoto Matsuyama,
  • Victoria Harle,
  • Victoria Offord,
  • Alastair Droop,
  • Roy Rabbie,
  • Manik Garg,
  • Martha Estefania Vázquez-Cruz,
  • Carla Daniela Robles-Espinoza,
  • Gemma Turner,
  • David Fraser,
  • Érica Aparecida de Oliveira,
  • Danielle Gonçalves de Carvalho,
  • Natasha Andressa Nogueira Jorge,
  • Mariana Boroni,
  • Patricia A. Possik,
  • David J. Adams,
  • Silvya Stuchi Maria-Engler

DOI
https://doi.org/10.1016/j.phrs.2025.107785
Journal volume & issue
Vol. 217
p. 107785

Abstract

Read online

SIN3 is a critical component of the histone deacetylase complex. Utilizing whole transcriptome data from melanoma patient samples we reveal that elevated levels of SIN3B are associated with poor survival outcomes with in vitro studies showing increased SIN3B expression in BRAF-mutant metastatic melanoma cell lines. The generation of isogenic SIN3B knockout cell lines indicated that SIN3B disruption led to a decrease in pathways associated with tumor invasion, migration, and cell-cell interactions. Moreover, pooled genome-wide CRISPR/Cas9 screens highlighted POLE4 and STK11 as crucial for the fitness and survival of SIN3B-knockout melanoma cells suggesting a role for these genes in epistasis with SIN3B. In summary, our findings suggest that SIN3B plays a pivotal role in modulating the behavior of melanoma cells, with implications for tumor growth and response to therapy.

Keywords